1. Introduction

Biotechnology Autonomous-Research Liability in Russia concerns the legal responsibility of researchers, biotechnology companies, scientific institutions, laboratories, manufacturers, software developers and public authorities when autonomous or AI-driven research systems cause harm during biotechnology experiments or scientific investigations.

Autonomous biotechnology research may involve:

Artificial intelligence conducting genetic research.

Automated laboratories performing DNA sequencing and gene editing.

Robotic systems conducting biological experiments.

AI-based drug discovery and molecular engineering.

Autonomous systems analysing human genetic and medical data.

Automated development of vaccines and biological products.

Gene-editing technologies such as CRISPR-Cas9.

AI-controlled biological sample storage and testing.

The central legal question is:

Who is legally responsible when an autonomous research system makes an error, performs an unauthorised experiment, damages biological material, produces an unsafe research result or causes injury to a human being or the environment?

Russian law does not generally recognise autonomous AI or robotic research systems as independent legal persons. Consequently, liability must ordinarily be attributed to identifiable human beings or legal entities through existing civil, administrative, criminal, healthcare, environmental and information-protection laws.

2. Legal framework governing autonomous biotechnology research

Russia does not have one comprehensive statute specifically establishing liability for autonomous biotechnology research. Instead, several federal laws operate together.

A. Civil Code of the Russian Federation

The Civil Code of the Russian Federation is the principal source of compensation liability.

The following provisions are particularly important:

Application to autonomous biotechnology:

Suppose a Russian biotechnology laboratory operates an AI-controlled gene-editing machine. The machine incorrectly modifies biological material, resulting in injury to a research employee.

The laboratory may face liability under Article 1064 if the injury resulted from negligent supervision, unsafe laboratory procedures or failure to maintain the equipment.

Article 1068 may also apply where the employee's wrongful conduct occurred in the performance of employment duties.

Article 1079 becomes relevant if the particular equipment or activity qualifies as a source of increased danger. However, not every AI-controlled laboratory or biotechnology experiment automatically falls within this provision.

Article 1095 may apply where injury results from defective equipment, research-related services or work supplied to a consumer within the scope of the provision.

The central principle is that technological autonomy does not automatically eliminate the legal responsibility of the organisation operating the system.

rospatent.gov.ru+1

B. Federal Law No. 86-FZ of 5 July 1996 — Genetic Engineering Activities

The Federal Law No. 86-FZ is particularly important for biotechnology research.

It regulates genetically engineered activities, environmental protection, ecological safety and protection of human health.

Its principal liability provision is Article 12.

Article 12 establishes that individuals and legal entities conducting genetic engineering activities may be held responsible under Russian legislation when their actions or omissions cause harm to:

Personnel working in genetic engineering organisations.

Members of the public.

The environment.

This provision is particularly relevant to autonomous laboratories.

For example, where an AI-controlled research platform accidentally releases a genetically modified organism beyond authorised containment conditions, the responsible organisation may face liability under the applicable genetic engineering and environmental laws.

The legal responsibility is not transferred to the AI merely because it selected the experimental procedure or activated the equipment.

Importantly, the 2022 amendments under Federal Law No. 643-FZ expanded the relevance of genetic information and genetic data within the statutory framework.

Faolex+2

C. Federal Law No. 323-FZ of 21 November 2011 — Protection of Citizens' Health

The Federal Law No. 323-FZ is relevant when autonomous biotechnology research involves human participants, clinical investigations, medical interventions or biological materials.

Its importance includes:

Protection of patients' rights.

Informed voluntary consent.

Medical confidentiality.

Requirements concerning medical interventions.

Duties of medical organisations and healthcare professionals.

Compensation for harm resulting from improper medical assistance.

An AI-based research system cannot replace the legal requirements for obtaining valid consent from a human participant.

If an autonomous research platform uses a patient's genetic information for an unauthorised experiment, the institution may face civil, regulatory and potentially criminal consequences depending on the circumstances.

D. Federal Law No. 152-FZ of 27 July 2006 — Personal Data

The Federal Law No. 152-FZ is relevant because genetic and medical research may involve sensitive personal information.

Autonomous research platforms can collect, analyse, store and transfer:

DNA sequences.

Genetic profiles.

Medical histories.

Biomarker information.

Biological identification information.

Health-related research records.

The research organisation must establish a lawful basis for processing personal data and comply with applicable security and confidentiality obligations.

An AI system that accidentally exposes a genetic database does not become the legal defendant in place of the data operator or other responsible persons.

E. Additional legislation

Other important legislation includes:

The precise legislation applicable depends on whether the autonomous system is performing basic research, genetic engineering, medical research, commercial drug development or environmental experimentation.

3. Who is responsible for autonomous biotechnology research failures?

Russian law requires the circumstances of each incident to be examined. Responsibility may be distributed among several actors.

Important distinction: The developer is not automatically liable whenever an AI system makes an error. A claimant must establish the applicable legal grounds, such as a product defect, wrongful conduct, causation or another statutory basis.

Where several parties jointly cause the same injury, Article 1080 of the Civil Code may become relevant.

4. Important Russian case laws and judicial precedents

There is an important limitation in Russian biotechnology jurisprudence: there is no established reported Supreme Court decision specifically deciding liability for harm caused by an autonomous AI-controlled biotechnology research system.

Nevertheless, several judicial decisions provide relevant legal principles.

Case 1. Supreme Court of the Russian Federation — Case No. 9-АД23-12-К1 (19 September 2023)

Direct biotechnology relevance

Court: Supreme Court of the Russian Federation.

Subject: Unregistered genetically modified organisms and unlawful use of GMO seeds.

Facts:

The company ООО «КиПиАй Агро Сеченово», subsequently identified as Агрохолдинг КиПиАй, used genetically modified rapeseed containing the cp4 EPSPS gene on agricultural fields in the Nizhny Novgorod region.

The regulatory authority discovered that the relevant GMO material had not received the required state registration for the relevant use.

The company challenged the administrative penalty.

Legal issue:

Whether the company's use of unregistered genetically modified organisms violated Russian genetic engineering legislation.

Decision:

On 19 September 2023, the Supreme Court upheld the previous decisions finding the company administratively liable under Article 6.3.1 of the Russian Code of Administrative Offences.

An administrative fine of 250,000 rubles remained in force.

Legal principles:

GMO-related activities must comply with applicable registration requirements.

Organisations conducting regulated biotechnology activities must take appropriate compliance measures.

Scientific and technical activities do not automatically exempt an organisation from regulatory requirements.

A legal entity may be administratively liable where it had the opportunity to comply but failed to take all necessary measures.

Application to autonomous research liability:

Suppose an autonomous biotechnology platform selects genetically modified organisms and initiates experiments involving their unauthorised environmental release.

The organisation cannot avoid regulatory responsibility merely by arguing that the AI independently selected the experimental material.

The decision is particularly relevant to organisational responsibility for controlling biotechnology operations.

ГАРАНТ+1

Case 2. Supreme Court Plenary Ruling No. 49 of 30 November 2017

Environmental liability precedent

Court: Supreme Court of the Russian Federation.

Subject: Compensation for environmental damage.

Legal issue:

How should Russian courts determine liability for environmental damage resulting from commercial or other activities?

Decision and principles:

The Supreme Court clarified that:

Environmental damage must be compensated in accordance with applicable legislation.

The claimant must establish the existence of damage, its amount and the causal connection with the defendant's conduct.

Liability may arise independently of fault where the law provides for strict liability.

Multiple persons jointly causing environmental damage may be jointly and severally liable.

Restoration of environmental damage does not necessarily eliminate separate liability for injury to human health or property.

Application to autonomous biotechnology:

Consider a research facility using autonomous microorganisms or genetically engineered biological materials.

If an autonomous system causes an uncontrolled biological release, the facility may be required to restore environmental damage and compensate affected persons where the relevant legal requirements are established.

This ruling is particularly important because it explains how environmental liability can operate even when the immediate physical event was produced by automated equipment.

vsrf.ru+1

Case 3. Russian Supreme Court principles under Article 1079 of the Civil Code

Subject: Liability for activities involving increased danger.

Article 1079 establishes a special liability regime for persons or organisations possessing sources of increased danger.

The Supreme Court's Plenary Ruling No. 49 explains the relationship between ordinary fault-based environmental liability and the special liability regime under Article 1079.

Application:

Where a biotechnology facility operates equipment or processes that legally qualify as sources of increased danger, the responsible owner or lawful possessor may face liability without proof of fault.

However, the classification must be established from the nature of the activity and applicable legislation. It would be incorrect to assume that every autonomous laboratory automatically qualifies.

This precedent is useful in disputes involving dangerous biological materials, specialised equipment and hazardous research operations.

vsrf.ru+1

Case 4. Russian judicial approach to AI legal responsibility

Subject: Legal status and responsibility for artificial intelligence.

Russian academic legal scholarship, including the 2024 article by Dmitriy V. Bakhteev, The Legal Status of Artificial Intelligence Systems and Models of Differentiation of Legal Liability for Damage Caused by Them, examines whether intelligent systems should possess independent legal status.

The research discusses different models for attributing responsibility for harm caused by AI.

It is not a judicial judgment, but it provides an important theoretical foundation for analysing autonomous biotechnology.

Application:

An autonomous research platform may independently:

Select experimental parameters.

Analyse genetic sequences.

Modify research protocols.

Identify molecular compounds.

Control laboratory instruments.

Nevertheless, operational independence does not itself establish legal personality.

The existing liability framework therefore requires examination of the developer, operator, research institution and other legally responsible persons.

crimescience.ru+1

5. Administrative liability for autonomous biotechnology research

Administrative responsibility may arise where an autonomous research system is used in violation of statutory requirements.

The Code of Administrative Offences of the Russian Federation is important in this respect.

Article 6.3.1 — Violations involving genetically engineered activities

This provision addresses specified violations involving the use of genetically modified organisms and products without required registration, outside authorised purposes or in breach of special conditions.

It was central to the 2023 Supreme Court decision discussed above.

Other provisions may become relevant depending on the circumstances, including:

Article 6.3: Violations of sanitary and epidemiological requirements.

Article 8.2: Violations of requirements concerning production and consumption waste.

Article 8.1: Non-compliance with environmental protection requirements when conducting activities.

The precise provision must be selected according to the actual conduct, rather than simply because AI was involved.

Example:

A biotechnology research institution programs an autonomous laboratory to conduct experiments with genetically modified organisms.

The system operates outside the applicable registration conditions.

The regulatory authorities may investigate the institution, its officials and other legally responsible persons under the relevant administrative provisions.

6. Criminal liability for autonomous biotechnology research failures

The Russian Criminal Code may apply where autonomous biotechnology research results in serious unlawful consequences and the necessary elements of a criminal offence are established.

Important provisions include:

These provisions do not automatically apply to every failed experiment.

The prosecution must establish the elements of the particular offence, including the required form of fault, causation and the defendant's legally relevant conduct.

Example: negligent autonomous laboratory operation

Imagine that a laboratory director authorises an autonomous biological research system to conduct experiments without adequate safety controls.

The system causes an accident, and a laboratory employee dies.

Depending on the evidence, the investigation may examine:

Whether the director had a legal duty to maintain safety.

Whether appropriate safety measures were omitted.

Whether the accident was foreseeable.

Whether the omission caused the death.

Whether the relevant criminal offence's negligence requirements are satisfied.

The AI system itself is not a criminal defendant under the ordinary Russian framework.

Individual criminal responsibility must be established separately; an institutional accident does not automatically make the director criminally liable.

7. Liability for different types of autonomous biotechnology research

8. Liability for unauthorised human experimentation

One of the most serious legal issues arises when autonomous biotechnology systems conduct experiments involving human beings.

For example, an AI research system might independently select a patient for genetic testing or initiate an experimental biological intervention.

Such autonomy does not remove the legal requirement for an appropriate legal basis and the applicable consent and medical safeguards.

Relevant principles include:

A. Informed consent

Human participants must receive legally adequate information and provide consent where required by the applicable medical and research legislation.

B. Protection of human dignity

Article 21 of the Russian Constitution protects human dignity and prohibits treatment incompatible with human dignity.

C. Medical confidentiality

Medical and genetic information must be protected under applicable healthcare and personal-data legislation.

D. Compensation

Where an unlawful experiment causes physical injury, psychological suffering or other legally recognised harm, compensation may be available under the Civil Code and relevant special legislation.

An organisation cannot use an AI-generated consent recommendation as a substitute for legally valid human consent.

9. Liability for autonomous research errors and scientific misconduct

Autonomous research systems can generate inaccurate scientific results or perform experiments in ways that were not anticipated by their developers.

Russian law may address these incidents through several legal doctrines.

A. Negligent supervision

A research institution may be responsible when it fails to supervise an autonomous system adequately.

B. Defective research equipment

A manufacturer or supplier may face liability if defective equipment causes injury and the statutory requirements for liability are met.

C. Research-data manipulation

If researchers deliberately manipulate AI-generated experimental results, falsify scientific evidence or conceal safety incidents, relevant civil, administrative or criminal provisions may apply.

D. Unauthorised experimentation

An institution may face liability if it permits autonomous research to operate outside applicable authorisations or safety restrictions.

E. Failure to preserve research records

Inadequate experimental documentation may create evidentiary difficulties and potentially demonstrate failures to meet applicable regulatory or contractual obligations.

10. Evidence and burden of proof

Proving liability in autonomous biotechnology disputes can be difficult because the immediate cause of an incident may involve complex interactions between software, biological materials, laboratory equipment and human decisions.

Important evidence includes:

AI-generated experimental logs.

Laboratory operating records.

Software versions and algorithm configurations.

DNA sequencing results.

Biological sample records.

Safety inspection reports.

Research authorisations and approvals.

Employee instructions and supervision records.

Expert scientific assessments.

Records identifying who authorised and controlled the experiment.

Under Article 1064 of the Civil Code, the general tort framework requires examination of the harm, wrongful conduct, causation and fault, subject to applicable legal presumptions and special liability rules.

For environmental damage, the Supreme Court's Plenary Ruling No. 49 provides additional guidance on proving damage and causation.

11. Major legal challenges

The Russian autonomous biotechnology liability framework faces several unresolved issues.

1. Absence of specific AI liability legislation

There is no comprehensive special civil-liability regime exclusively governing autonomous biotechnology research systems.

2. Attribution of responsibility

It can be difficult to determine whether the developer, researcher, laboratory operator or institution should bear responsibility.

3. Algorithmic unpredictability

AI systems may produce results that are difficult to anticipate or explain.

4. Scientific causation

Establishing that a particular autonomous experiment caused a biological injury may require specialised scientific evidence.

5. Cross-border responsibility

A research platform may be developed abroad, operated in Russia and connected to international genetic databases. This raises questions about jurisdiction, applicable law and international cooperation.

6. Regulatory uncertainty

Existing biotechnology legislation was not designed specifically for fully autonomous laboratories capable of independently changing experimental procedures.

12. Recommendations for strengthening Russian law

Several reforms could improve the legal framework.

A particularly useful reform would be to establish a statutory distinction between the responsibilities of AI developers, laboratory operators and research institutions.

Such legislation could consider actual control over the system, foreseeability of the risk, the ability to prevent the incident and the party's failure to implement reasonable safeguards.

These are proposals for legislative development, not existing general statutory requirements.

13. Hypothetical case study

Case: Autonomous CRISPR Research Laboratory Accident

Consider a hypothetical biotechnology company operating an autonomous CRISPR research laboratory in Moscow.

The AI platform independently modifies its experimental parameters and initiates a biological experiment outside the institution's approved safety procedures.

An accidental release of genetically modified biological material causes environmental contamination and injuries to laboratory personnel.

Legal analysis:

Possible judicial outcome:

The company could be required to compensate injured persons and restore environmental damage where the relevant conditions are established.

Its management could face separate administrative or criminal proceedings if their own legally relevant conduct satisfies the applicable statutory requirements.

The equipment developer could also face liability if a defect or other legally actionable failure is established.

The AI platform itself would not ordinarily be treated as an independent legal person.

This is a hypothetical illustration, not an actual Russian court judgment.

14. Conclusion

Biotechnology Autonomous-Research Liability in Russia is governed principally by the interaction of civil liability, genetic engineering regulation, environmental protection, healthcare legislation, personal-data protection and criminal law.

The Civil Code establishes the general mechanisms for compensation, while Federal Law No. 86-FZ provides an important statutory foundation for responsibility arising from genetically engineered activities.

The Supreme Court's decision in Case No. 9-АД23-12-К1 demonstrates that organisations cannot avoid regulatory obligations when conducting activities involving genetically modified organisms. Plenary Ruling No. 49 of 2017 provides further guidance on environmental damage, causation and restoration.

However, Russian law has not yet established a comprehensive autonomous-biotechnology liability framework.

The central legal principle is that the autonomy of a research machine does not automatically eliminate the responsibility of the human beings and organisations legally responsible for its design, operation, supervision and research activities.

15. Important legal references and research sources

Constitution of the Russian Federation — Articles 21, 23, 41 and 42.

Civil Code of the Russian Federation — Articles 15, 1064, 1068, 1079 and 1080.

Federal Law No. 86-FZ of 5 July 1996 — Genetic Engineering Activities.

Federal Law No. 323-FZ of 21 November 2011 — Protection of Citizens' Health.

Federal Law No. 152-FZ of 27 July 2006 — Personal Data.

Federal Law No. 7-FZ of 10 January 2002 — Environmental Protection.

Code of Administrative Offences of the Russian Federation — Article 6.3.1.

Criminal Code of the Russian Federation — Articles 109, 118, 236, 246 and 247.

Supreme Court of the Russian Federation, Case No. 9-АД23-12-К1, 19 September 2023.

Supreme Court Plenary Ruling No. 49, 30 November 2017.

Further reading:

Russian Civil Code – full legislative text.

Federal Law No. 86-FZ – genetic engineering regulation.

Supreme Court Case No. 9-АД23-12-К1.

Supreme Court Plenary Ruling No. 49.

Academic research on AI legal status and liability (2024).

Academic qualification: This analysis distinguishes actual Russian judicial decisions from analogous legal precedents, academic commentary and hypothetical applications. The cited Civil Code translation is dated 21 April 2025; legislation and subsequent amendments should be checked against official Russian texts before litigation or formal legal submission.